Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
The Cooper Health System · NCT02749474
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 400
- US sites recruiting
- 1
- Study start
- July 1, 2003
- Record last updated
- October 22, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The objective of this study is to follow the treatment options offered to pregnant women diagnosed with cancer and study the impact that their treatment or delay of treatment has on their own health and that of their children.
Conditions: Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Any pregnant woman diagnosed with cancer within 6 weeks before her last menstrual period or 6 months after her end of pregnancy either by delivery or miscarriage.
Exclusion Criteria
- Women diagnosed with cancer more than 6 months after the end of a pregnancy.
Recruiting US locations
Cooper University Hospital
Camden, NJ 08103
Site contact: Elyce H Cardonick, MD · 8563422065 or 8567577876 · cancerandpregnancy@cooperhealth.edu
Study contacts (from the official record)
- Elyce H Cardonick, MD · 856342 2065 · cancerandpregnancy@cooperhealth.edu
- Harry Mazurek · 8563422000
Similar studies in New Jersey
All pregnancy studies in New Jersey →- RecruitingHealthy volunteersPhase 3
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Pfizer
- Location
- New Brunswick, NJ + 111 other US sites
- Eligibility basics
- Ages 0 mo–49
- RecruitingHealthy volunteers
Non-Invasive Preeclampsia Screening and Biobank
Sequenom, Inc.
- Location
- Livingston, NJ + 15 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 3
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
Aerogen Pharma Limited
- Location
- Morristown, NJ + 17 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 3
Brexanolone Lifting Outcomes Of Moms
Lipocine Inc.
- Location
- Princeton, NJ + 15 other US sites
- Eligibility basics
- Ages 15–45 · Women only